Full-length nuclear receptor allosteric regulation
Journal of Lipid Research · 2023-08 · 64 (8) · 100406
DOI: 10.1016/j.jlr.2023.100406 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Lipid Research, 2023-08. Verfasst von Woong Jae Choi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Transcription Factors. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Nuclear receptors are a superfamily of transcription factors regulated by a wide range of lipids that include phospholipids, fatty acids, heme-based metabolites, and cholesterol-based steroids. Encoded as classic two-domain modular transcription factors, nuclear receptors possess a DNA-binding domain (DBD) and a lipid ligand-binding domain (LBD) containing a transcriptional activation function. Decades of structural studies on the isolated LBDs of nuclear receptors established that lipid-ligand binding allosterically regulates the conformation of the LBD, regulating transcriptional coregulator recruitment and thus nuclear receptor function. These structural studies have aided the development of several FDA-approved drugs, highlighting the importance of understanding the structure-function relationships between lipids and nuclear receptors. However, there are few published descriptions of full-length nuclear receptor structure and even fewer descriptions of how lipids might allosterically regulate full-length structure. Here, we examine multidomain interactions based on the published full-length nuclear receptor structures, evaluating the potential of interdomain interfaces within these nuclear receptors to act as inducible sites of allosteric regulation by lipids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
- Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt University Center for Structural Biology, Nashville, TN, USA; Program in P…
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Choi, W. J., Haratipour, Z., & Blind, R. D. (2023). Full-length nuclear receptor allosteric regulation. Journal of Lipid Research, 64(8), 100406. https://doi.org/10.1016/j.jlr.2023.100406
Vancouver
Choi WJ, Haratipour Z, Blind RD. Full-length nuclear receptor allosteric regulation. Journal of Lipid Research. 2023;64(8):100406. doi:10.1016/j.jlr.2023.100406
BibTeX
@article{Choi2023,
author = {Choi, Woong Jae and Haratipour, Zeinab and Blind, Raymond D},
title = {Full-length nuclear receptor allosteric regulation},
journal = {Journal of Lipid Research},
year = {2023},
volume = {64},
number = {8},
pages = {100406},
doi = {10.1016/j.jlr.2023.100406}
}
EUVIMED